March 2013 LAM NZ update
Bronwyn Gray, the NZ LAM Trust’s Director met recently in Melbourne with LAM patient, Heather Telford, immediate past president of LARA (LAM Austrlasia Research Alliance) and with Gill Hollings from LAM Action, United Kingdom.
The University of Auckland honours NZ LAM Trust Research Scientist: Dr Jilly Evans.
On March 1st, New Zealander, Dr Jilly Evans received the Distinguished Alumni Award at a dinner in her honour at the University of Auckland.
Dr Evans, who completed her Masters of Science with First Class honours at the University of Auckland, before completing her PhD in Canada, is a world renowned research scientist, who has had involvement in scientific investigation into LAM for the past 14 years.
Dr Evans, is a scientist and innovator who has led major drug development programmes in Canada and in the United States and the NZ LAM Trust is proud to have such a renowned champion involved with our organisation.
Following on from more than a 20 year career with the giant Merck Frost, pharmaceutical company, Dr Evans and her colleagues recently founded PharmAria Therapeutics in San Diego where they are developing small molecule drugs to treat cancers and fibrotic diseases.
A member of the American LAM Foundation Scientific Advisory Board, Dr Evans has a keen interest in global LAM investigation and a personal interest in ongoing NZ LAM research programmes and LAM patient advocacy and support in New Zealand.
The LAM Trust congratulates Dr Evans on her Distinguished Alumni honour.
Tim Weaver of Waiheke Island will participate {in honour of LAM NZ} in the Lake Taupo Cycle Challenge – cyling 160km on November 24th.
